Acute Erythroblastic Leukemia

Search Trials
Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia
Status:
Completed
Last Changed:
Dec 5, 2012
First Changed:
Aug 26, 2005
Disease(s):
Leukemia, Myelocytic, Acute
Intervention(s):
Cladribine, Cyclophosphamide, Cytarabine, Daunorubicin, DexamethasoneEtoposide, Cytarabine, Gemtuzumab, L-asparaginase, Mercaptopurine, methotrexate, Mitoxantrone, Prednisone, Vincristine
Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia
Status:
Completed
Last Changed:
Jun 26, 2015
First Changed:
Jan 27, 2003
Disease(s):
Leukemia
Intervention(s):
filgrastimsargramostimcytarabinedaunorubicin hydrochloridezosuquidar trihydrochloridePlacebo
A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status
Status:
Completed
Last Changed:
May 11, 2020
First Changed:
Apr 19, 2007
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
AC220
Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Status:
Terminated
Last Changed:
Feb 7, 2022
First Changed:
Dec 9, 2009
Disease(s):
Acute Biphenotypic Leukemia
Intervention(s):
CyclophosphamideFilgrastimFludarabine PhosphateLaboratory Biomarker AnalysisMycophenolate MofetilNonmyeloablative Allogeneic Hematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationTacrolimusTotal-Body IrradiationFludarabine
Efficacy and Safety of HVA Regimens as Salvage Treatment in rrAML
Status:
Enrolling by invitation
Last Changed:
Jun 9, 2020
First Changed:
Jun 9, 2020
Disease(s):
Refractory Acute Myeloid Leukemia
Intervention(s):
HVA Regimens as Salvage Treatment

Connect. Empower. Inspire.